VintaBio, which debuted in 2023 as a CDMO focused on cranking out viral vectors for cell and gene therapy production, is having its manufacturing facility and intellectual property put up for sale.
VintaBio assets go on auction block as CGT viral vector demand slows
Latest from Blog
Common Sleep Apnea Test May Miss The Condition In Black Patients
MONDAY, Oct. 12, 2026 A common test used to diagnose obstructive sleep apnea may miss the condition in Black patients, potentially affecting important treatment Post Views: 1
STAT+: Beyond statins, one drug lowered heart attack risk by 20%
When statins aren’t enough, other cholesterol-lowering drugs come into play. But which one is most effective? Cardiologists looking to help their patients reduce the amount of LDL, or “bad,” cholesterol threatening to
Single-payer health care system proponents were thrown a big bone this election
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. We’ve got great stories below that flesh out the implications of the Democrats’ rout
Which Legal Substance Is Most Likely To Help Land You In The Hospital? Depends On Your Age
THURSDAY, Nov. 5, 2026 Which legal substance is most likely to help land you in the emergency room It depends on your age, a new study says.Weed is the substanc Post Views:
One-Third Of Infant Peanut Allergy Cases Might Be Misdiagnosed, Study Reports
THURSDAY, Nov. 5, 2026 Five-month-old Arthur s face reddened the first time he ate peanut, and hives broke out on his shoulders and upper lip. Our GP referred u Post Views: 1